Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke

Condition:   Acute Ischemic Stroke Intervention:   Biological: UMC119-06 Sponsor:   Meridigen Biotech Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials